Who are 10x Genomics's decision-makers?

Serge Saxonov serves as Co-founder and Chief Executive Officer; Justin McAnear serves as Chief Financial Officer; Michael Schnall-Levin serves as Chief Technology Officer; Ben Hindson serves as Co-founder and President. The team combines category, finance, commercial, clinical, technical, and operations ownership.

For account mapping, treat the named leaders as executive context rather than the only buying path. Most projects will start with a functional sponsor and move upward only after a clear business case exists.

Budget ownership depends on the project: commercial leaders own revenue tools, clinical and product leaders own workflow and evidence needs, technology leaders own platform and security fit, and finance or procurement controls approval thresholds.

Because 10x Genomics operates in healthcare or life sciences, legal, privacy, compliance, quality, and information-security review can be as important as the economic buyer.

10x Genomics should be approached as a public-company operating organization with business units, functional teams, and governance layers. The company has 1,200+ employees and operates from Pleasanton, CA with additional offices or distributed teams.

Good account plans identify the operational metric at stake, the system of record involved, the compliance requirement, the implementation owner, and the executive sponsor before asking for a broad enterprise commitment.